Immunochemical analysis of iron transporters and M2 macrophages in ovarian endometrioma and clear cell adenocarcinoma

Akashi,Keiko; Nagashima,Yoji; Tabata,Tsutomu; Oda,Hideaki

doi:10.3892/mco.2021.2321

Immunochemical analysis of iron transporters and M2 macrophages in ovarian endometrioma and clear cell adenocarcinoma

Authors:
- Keiko Akashi
- Yoji Nagashima
- Tsutomu Tabata
- Hideaki Oda
View Affiliations

Affiliations: Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162‑8666, Japan, Department of Surgical Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162‑8666, Japan, Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Shinjuku, Tokyo 162‑8666, Japan
Published online on: June 11, 2021 https://doi.org/10.3892/mco.2021.2321
Article Number: 159
Copyright: © Akashi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The association between iron ions and endometriosis‑associated ovarian cancer (EAOC) has been previously investigated to elucidate EAOC carcinogenesis; however, the dynamics of iron deposition in the endometrial epithelium and endometrial stroma of ovarian endometrioma (OE) remains unknown. The present study aimed to determine the expression of iron transporters on the cell surface and the distribution of tumor‑associated macrophages (TAMs) englobed with iron in the endometrial stroma. The current retrospective study investigated 20 OE and 18 ovarian clear cell adenocarcinoma (CCC) samples, using Perls Prussian blue staining and immunohistochemistry of iron transporters, including divalent metal transporter 1 (DMT1), transferrin receptor (TfR) and ferroportin (FPN). Additionally, samples were stained for CD68, CD11c, CD163 and CD206, and double‑immunostained for iron and CD163 to define the distribution of macrophages. Iron transporters were identified on the endometrial epithelium of OE and CCC tumor cells, and TAMs were englobed with iron in the endometrial stroma of OE and CCC. Histological findings revealed DMT1 upregulation in OE and CCC, whereas lower TfR and FPN expression was observed in OE than in CCC. M2 macrophages were englobed with iron ions in the deep layers of the OE and CCC stroma. The endometrial epithelium located in the endometrial stroma of one patient with OE and the endometrial epithelium adjacent to CCC in two patients with CCC stained positive for the tumor proliferation marker Ki67. Epithelium infiltrating the stroma of OE may become the origin of cancer under the influence of M2 macrophages englobed with iron. These findings provide new perspectives on the malignant transformation of OE into EAOC and its possibility as a precancerous index.

View Figures

View References

1	Giudice LC and Kao LC: Endometriosis. Lancet. 364:1789–1799. 2004.PubMed/NCBI View Article : Google Scholar
2	Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA and Zondervan KT: Priorities for endometriosis research: Recommendations from an international consensus workshop. Reprod Sci. 16:335–346. 2009.PubMed/NCBI View Article : Google Scholar
3	Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, et al: Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol. 13:385–394. 2012.PubMed/NCBI View Article : Google Scholar
4	Fukunaga M, Nomura K, Ishikawa E and Ushigome S: Ovarian atypical endometriosis: Its close association with malignant epithelial tumours. Histopathology. 30:249–255. 1997.PubMed/NCBI View Article : Google Scholar
5	Machida H, Matsuo K, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T and Mikami M: Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol. 153:589–596. 2019.PubMed/NCBI View Article : Google Scholar
6	Hooper G: The diagnosis and treatment of endometriosis. Can Med Assoc J. 42:243–246. 1940.PubMed/NCBI
7	Clement PB: The pathology of endometriosis: A survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol. 14:241–260. 2007.PubMed/NCBI View Article : Google Scholar
8	Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res. 14:32–40. 2008.PubMed/NCBI View Article : Google Scholar
9	Fujimoto Y, Imanaka S, Yamada Y, Ogawa K, Ito F, Kawahara N, Yoshimoto C and Kobayashi H: Comparison of redox parameters in ovarian endometrioma and its malignant transformation. Oncol Lett. 16:5257–5264. 2018.PubMed/NCBI View Article : Google Scholar
10	Greenshields AL, Shepherd TG and Hoskin DW: Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol Carcinog. 56:75–93. 2017.PubMed/NCBI View Article : Google Scholar
11	Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL and Hediger MA: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:482–488. 1997.PubMed/NCBI View Article : Google Scholar
12	Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T and Kishi F: Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem. 275:22220–22228. 2000.PubMed/NCBI View Article : Google Scholar
13	Ross SL, Tran L, Winters A, Lee KJ, Plewa C, Foltz I, King C, Miranda LP, Allen J, Beckman H, et al: Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 15:905–917. 2012.PubMed/NCBI View Article : Google Scholar
14	Gammella E, Buratti P, Cairo G and Recalcati S: The transferrin receptor: The cellular iron gate. Metallomics. 9:1367–1375. 2017.PubMed/NCBI View Article : Google Scholar
15	Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549–555. 2002.PubMed/NCBI View Article : Google Scholar
16	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004.PubMed/NCBI View Article : Google Scholar
17	Yamada Y, Uchiyama T, Ito F, Kawahara N, Ogawa K, Obayashi C and Kobayashi H: Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma. Pathol Res Pract. 215:639–643. 2019.PubMed/NCBI View Article : Google Scholar
18	Canet B, Pons C, Espinosa I and Prat J: CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis. Hum Pathol. 43:720–725. 2012.PubMed/NCBI View Article : Google Scholar
19	Toki T, Shimizu M, Takagi Y, Ashida T and Konishi I: CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol. 21:41–47. 2002.PubMed/NCBI View Article : Google Scholar
20	Chandler RL, Damrauer JS, Raab JR, Schisler JC, Wilkerson MD, Didion JP, Starmer J, Serber D, Yee D, Xiong J, et al: Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 6(6118)2015.PubMed/NCBI View Article : Google Scholar
21	Yamamoto S, Tsuda H, Takano M, Tamai S and Matsubara O: Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol. 25:615–624. 2012.PubMed/NCBI View Article : Google Scholar
22	Samartzis EP, Noske A, Dedes KJ, Fink D and Imesch P: ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci. 14:18824–18849. 2013.PubMed/NCBI View Article : Google Scholar
23	Huang HN, Lin MC, Huang WC, Chiang YC and Kuo KT: Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma. Mod Pathol. 27:983–990. 2014.PubMed/NCBI View Article : Google Scholar
24	Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012.PubMed/NCBI View Article : Google Scholar
25	Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S and Andrews NC: The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1:191–200. 2005.PubMed/NCBI View Article : Google Scholar
26	Schümann K, Moret R, Künzle H and Kühn LC: Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa. Possible implications for the regulation of iron absorption. Eur J Biochem. 260:362–372. 1999.PubMed/NCBI View Article : Google Scholar
27	Miyazawa M, Bogdan AR, Hashimoto K and Tsuji Y: Regulation of transferrin receptor-1 mRNA by the interplay between IRE-binding proteins and miR-7/miR-141 in the 3'-IRE stem-loops. RNA. 24:468–479. 2018.PubMed/NCBI View Article : Google Scholar
28	Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino R Jr, Torti SV and Torti FM: An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 71:6728–6737. 2011.PubMed/NCBI View Article : Google Scholar
29	Xue X, Ramakrishnan SK, Weisz K, Triner D, Xie L, Attili D, Pant A, Győrffy B, Zhan M, Carter-Su C, et al: Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab. 24:447–461. 2016.PubMed/NCBI View Article : Google Scholar
30	Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP, et al: Iron addiction: A novel therapeutic target in ovarian cancer. Oncogene. 36:4089–4099. 2017.PubMed/NCBI View Article : Google Scholar
31	Takaishi K, Komohara Y, Tashiro H, Ohtake H, Nakagawa T, Katabuchi H and Takeya M: Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation. Cancer Sci. 101:2128–2136. 2010.PubMed/NCBI View Article : Google Scholar
32	Tran-Harding K, Nair RT, Dawkins A, Ayoob A, Owen J, Deraney S, Lee JT, Stevens S and Ganesh H: Endometriosis revisited: An imaging review of the usual and unusual manifestations with pathological correlation. Clin Imaging. 52:163–171. 2018.PubMed/NCBI View Article : Google Scholar
33	Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et al: ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 363:1532–1543. 2010.PubMed/NCBI View Article : Google Scholar
34	Yachida N, Yoshihara K, Suda K, Nakaoka H, Ueda H, Sugino K, Yamaguchi M, Mori Y, Yamawaki K, Tamura R, et al: ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: Implication for the two-hit hypothesis. Sci Rep. 10(14260)2020.PubMed/NCBI View Article : Google Scholar